Asuragen Looks to Lure Pharma with miRNA Service | GenomeWeb

Betting that informatics know-how and novel content will distinguish it from rivals in the microRNA array space, Asuragen launched its DiscovArray miRNA Expression Services, which use an Affymetrix-manufactured array to screen all validated miRNAs from the Sanger Center’s miRBase repository as well as 12,000 exploratory human miRNAs.

The company hopes that it can attract customers that would rather outsource miRNA expression profiling projects than buy a catalog array from firms like Exiqon and Agilent Technologies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.